Barclays Maintains Overweight Rating for Healthpeak Properties: Here's What You Need To Know

Barclays has decided to maintain its Overweight rating of Healthpeak Properties PEAK and lower its price target from $33.00 to $32.00.

Shares of Healthpeak Properties are trading down 0.16% over the last 24 hours, at $22.09 per share.

A move to $32.00 would account for a 44.89% increase from the current share price.

About Healthpeak Properties

Healthpeak owns a diversified healthcare portfolio of approximately 463 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.